GENMARK DIAGNOSTICS INC - COM (GNMK)

CUSIP: 372309104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
57,323,157
Share change
-2,093,781
Total reported value
$239,056,112
Price per share
$4.17
Number of holders
96
Value change
-$34,895,638
Number of buys
50
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 372309104?
CUSIP 372309104 identifies GNMK - GENMARK DIAGNOSTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q4 2017

As of 31 Dec 2017, GENMARK DIAGNOSTICS INC - COM (GNMK) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,323,157 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, CADIAN CAPITAL MANAGEMENT, LP, JPMORGAN CHASE & CO, PUTNAM INVESTMENTS LLC, BlackRock Inc., Casdin Capital, LLC, Vanguard Group Inc, HighTower Advisors, LLC, and JENNISON ASSOCIATES LLC. This page lists 96 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.